Loading...
XSHE
002589
Market cap642mUSD
Oct 09, Last price  
3.35CNY
1D
3.72%
1Q
26.89%
Jan 2017
-75.77%
IPO
164.91%
Name

Realcan Pharmaceutical Group Co Ltd

Chart & performance

D1W1MN
XSHE:002589 chart
P/E
277.43
P/S
0.61
EPS
0.01
Div yield, %
0.12%
Shrs. gr., 5y
1.97%
Rev. gr., 5y
-19.10%
Revenues
7.30b
-8.42%
1,147,110,0001,601,731,0002,213,383,0003,195,448,0004,622,237,6185,925,841,6907,785,907,0769,749,957,91415,618,666,23623,293,620,45933,918,534,25535,258,509,45327,233,914,39021,059,718,89621,059,718,89512,311,277,75312,311,277,7538,034,367,9977,966,345,5767,295,858,461
Net income
16m
-22.07%
29,178,00044,757,00062,109,00084,057,000110,651,379143,554,934180,986,799235,938,550590,758,9501,008,211,784771,184,620-927,802,401261,302,755382,013,017131,178,2890-1,830,913,26420,317,69620,621,58916,071,175
CFO
14m
-91.42%
-49,876,00061,385,00070,557,000-475,032,000-170,520,000-274,459,000-163,621,000-466,262,000-1,759,046,000-2,421,912,000-201,660,0002,094,525,000414,956,000442,953,000523,074,00082,467,000160,445,00013,759,527
Dividend
Jun 30, 20260.002 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Realcan Pharmaceutical Group Co., Ltd. operates as a global supplier, distributing pharmaceuticals, vaccines, medical devices, and consumable medical products to healthcare institutions across the world. Beyond its core distribution activities, the company offers a suite of specialized services, including comprehensive medical logistics, third-party logistics solutions, disinfection and sterilization, and equipment leasing, alongside full-service hospital logistics support. Its operational reach spans diverse areas such as drug distribution, academic support services, medical diagnostics, financial technology applications, traditional Chinese medicine, digital health solutions, professional logistics, and integrated equipment management. The company, initially incorporated as Realcan Pharmaceutical Co., Ltd., adopted its current designation in December 2018. Realcan was established in 2004 and is headquartered in Yantai, China.

Key people

Xu Han
Chairman of the Board, President · since 2023
Yun Feng
Chief Financial Officer, Vice President · since 2021
Mingtao Yan
Vice President · since 2016
Zhe Li
Vice President, Secretary of the Board, Director · since 2023
Liyan Wu
Director · since 2023
Bo Yang
Vice President, Director · since 2016
Shoukai Zhang
Director · since 2023
Xijun Liu
Independent Director · since 2020
Kaoxiang Sun
Independent Director · since 2023
Jifa Wang
Independent Director · since 2023
URL
https://www.realcan.cn/
IPO date
Jun 10, 2011
Employees
Domiciled in
CN
Incorporated in
CN
Headquarters & legal address
烟台市芝罘区机场路326号
烟台市, SD 100000
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT